The All Wales Medicines Strategy Group started the assessment of ivacaftor (Kalydeco) as soon as the drug company formally engaged with the appraisal process. This process is recognised to be robust and normally takes about 21 weeks to allow all parties, including patient organisations such as the Cystic Fibrosis Trust, to submit their comments. The final appraisal decision for Kalydeco is scheduled to be reached at a public meeting on 8th May 2013.
More top news
Simon James, a second row for the Brynamman RFC’s second side, collapsed without warning as they took on Cefneithin RFC in April.
Visitors criticised inadequate numbers of toilets and food and drink stands, along with large queues.
Conner Marshall died of injuries in hospital after being found at the Trecco Bay holiday park in Porthcawl in March.